Glucose B. Braun

Glucose B. Braun is a sterile solution for injection that contains glucose monohydrate as its active ingredient. It is supplied as an intravenous carbohydrate solution without a listed strength, intended for use in parenteral nutrition, fluid and electrolyte replacement, and treatment of hypoglycemia. The product is marketed in the European Union and is available by prescription only.

Glucose B. Braun is employed in clinical settings where rapid delivery of carbohydrate energy is required. It supports patients who cannot receive nutrition orally or enterally.

- Management of hypoglycemia in acute care environments. - Component of parenteral nutrition regimens for adult and pediatric patients. - Fluid and electrolyte replacement during surgery or trauma. - Intra‑operative glucose supplementation to maintain blood sugar levels. - Post‑operative support for patients unable to resume oral intake. - Neonatal and infant nutrition when enteral feeding is not feasible.

Glucose B. Braun may cause a range of adverse reactions, most of which are mild and transient. Serious events are less common but require immediate medical attention.

Common: - Hyperglycemia or elevated blood glucose levels. - Local irritation at the infusion site. - Mild nausea or vomiting. - Headache. - Transient hypotension during rapid infusion.

Serious: - Severe hyperglycemia leading to diabetic ketoacidosis. - Allergic reaction or anaphylaxis. - Electrolyte imbalance, especially hypernatremia. - Fluid overload with pulmonary edema. - Metabolic acidosis in susceptible patients.

Healthcare professionals should assess patient-specific factors before administering Glucose B. Braun. Proper monitoring can reduce the risk of complications.

- Verify blood glucose levels prior to infusion and adjust rate accordingly. - Use caution in patients with diabetes mellitus or impaired glucose tolerance. - Monitor fluid balance to avoid overload, especially in heart or renal failure. - Assess electrolyte status, particularly sodium and potassium, before and during therapy. - Avoid rapid infusion rates that may cause hypotension. - Pregnant or lactating patients should be evaluated on a case‑by‑case basis. - Store the solution according to manufacturer instructions to maintain sterility.

Glucose B. Braun can interact with other medications or solutions administered intravenously. Some combinations should be avoided, while others require careful monitoring.

Avoid: - Concurrent infusion of high‑concentration potassium solutions, which may precipitate. - Co‑administration with insulin without appropriate glucose monitoring. - Use with medications that contain dextrose or other sugars, which could cause hyperglycemia.

Use with caution: - Loop diuretics, as they may exacerbate electrolyte shifts. - Beta‑blockers, which can mask signs of hypoglycemia. - Corticosteroids, which can increase glucose production. - Total parenteral nutrition admixtures, requiring compatibility testing. - Vasopressors, where rapid changes in osmolarity could affect hemodynamics.